SavedAdd your journal

Journals / Turkish Neurosurgery / 2019 / Cilt: 29 - Sayı: 1

Does the Anti-Migraine Drug Rizatriptan Affect Early Neural Tube Development in Chick Embryos?

Murat SAYIN
Gulsen Seren GURGEN
Sevgi Sidika SAYIN
Gönül GÜVENÇ
Nurullah YÜCEER
Pages
106–109
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Further research is needed to identify a safe and effectivedrug for treating migraines during pregnancy.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:AIM: To investigate the impact of rizatriptan on neural tube development using early chick embryos as a model organism.MATERIAL and METHODS: A total of 36 pathogen-free Leghorn chicken eggs were selected and categorized in three groups:sham, therapeutic, and supra-therapeutic.
📊
Key Findings & Data:After 24 hours, the eggs were opened and injected with sterile drugs, and then reclosed using plastic tape.
💡
Conclusion & Impact:Further research is needed to identify a safe and effectivedrug for treating migraines during pregnancy.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

AIM: To investigate the impact of rizatriptan on neural tube development using early chick embryos as a model organism.MATERIAL and METHODS: A total of 36 pathogen-free Leghorn chicken eggs were selected and categorized in three groups:sham, therapeutic, and supra-therapeutic. After 24 hours, the eggs were opened and injected with sterile drugs, and then reclosed using plastic tape. After a period of 72 hours, the eggs were opened and assessed using the Hamburger–Hamilton chickembryology classification method. TUNEL staining was used to identify apoptosis, and hematoxylin–eosin staining was used toinvestigate neural tube closure.RESULTS: Treatment with rizatriptan significantly slowed down neural tube development. The supra-therapeutic group showedneural tube closure defects.CONCLUSION: Rizatriptan had a negative effect on neural tube closure. Further research is needed to identify a safe and effectivedrug for treating migraines during pregnancy.

🔖

Cite This Article

SAYIN, M., GURGEN, G. S., SAYIN, S. S., GÜVENÇ, G., YÜCEER, N. (2019). Does the Anti-Migraine Drug Rizatriptan Affect Early Neural Tube Development in Chick Embryos?. Turkish Neurosurgery, Cilt: 29 - Sayı: 1, 106–109. https://ajindex.com/articles/405275

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Amundsen S, Nordeng H, Nezvalová-Henriksen K, Stovner LJ, Spigset O: Pharmacological treatment of migraine during pregnancy and breastfeeding. Nat Rev Neurol 11:209-219, 2015 2. Becker WJ: Acute migraine treatment in adults. Headache 55: 778-793, 2015 3. Blair EM, Nelson KB: Migraine and preterm birth. J Perinatol 31: 434-439, 2011 4. Bonnin A, Levitt P: Fetal, maternal, and placental sources of serotonin and new implications for developmental programming of the brain. Neuroscience 197: 1-7, 2011 5. Bousser MG, Massiou H: Migraine in the reproductive cycle. In: Olesen J, Tfelt-Hansen P, Welch KMA, eds, The Headaches. New York: Raven Press, 1991: 413-419 6. Cetinkal A, Colak A, Topuz K, Demircan MN, Simsek H, Berber U, Umur AS, Selcuki M, Vatansever HS: The effects of meloxicam on neural tube development in the early stage of chick embryos. Turk Neurosurg 20: 111-116, 2010 7. Ehi Y, Şahin L, Mutlu MF: Migraine management in pregnancy. Clin Exp Obstet Gynecol 43: 661-665, 2016 8. Facchinetti F, Allais G, Nappi RE, D’amico R, Marozio L, Bertozzi L, Ornati A, Benedetto C: Migraine is a risk factor for hypertensive disorders in pregnancy: A prospective cohort study. Cephalalgia 29: 286-292, 2009 9. Frederick IO, Qiu C, Enquobahrie DA, Aurora SK, Peterlin BL, Gelaye B, Williams MA: Lifetime prevalence and correlates of migraine among women in a pacific northwest pregnancy cohort study. Headache 54: 675-685, 2014 10. Gladstone JP, Eross EJ, Dodick DW: Migraine in special populations: Treatment strategies for children and adolescents, pregnant women, and the elderly. Postgrad Med 115: 39-50, 2004 11. Hamburger V, Hamilton HL: A series of normal stages in the development of the chick embryo. Dev Dyn 88: 49-92, 1951 12. Hauth JC, Ewell MG, Levine RJ, Esterlitz JR, Sibai B, Curet LB, Catalano PM, Morris CD; Calcium for Preeclampsia Prevention Study Group: Pregnancy outcomes in healthy nulliparas who developed hypertension. Obstet Gynecol 95: 24-28, 2000 13. Nappi G, Sandrini G, Sances G: Tolerability of the triptans: Clinical implications. Drug Saf 26: 93-107, 2003 14. Nezvalová-Henriksen K, Spigset O, Nordeng H: Maternal characteristics and migraine pharmacotherapy during pregnancy: Cross-sectional analysis of data from a large cohort study. Cephalalgia 29: 1267-1276, 2009 15. Sanchez SE, Williams MA, Pacora PN, Ananth CV, Qiu C, Aurora SK, Sorensen TK: Risk of placental abruption in relation to migraines and headaches. BMC Womens Health 10: 30, 2010 16. Silberst